Document is current
Any future updates will be listed below
-
Authors
Terheyden, Jan Henrik https://orcid.org/0000-0002-0174-4066
Dunbar, Hannah M. P.
Schmitz-Valckenberg, Steffen
Behning, Charlotte
Martinho, Cecília
Luhmann, Ulrich F. O. https://orcid.org/0000-0002-1993-1951
Saßmannshausen, Marlene
Lüning, Anna
Miliu, Alexandra
Aires, Inês Dinis
Basile, Pier Giorgio
Batuca, Joana
Schmid, Matthias
Moll, Klaus-Peter
Zakaria, Nadia
Tufail, Adnan https://orcid.org/0000-0001-6131-7640
Binns, Alison
Crabb, David P. https://orcid.org/0000-0001-8754-3902
Leal, Sergio
Finger, Robert P.
Holz, Frank G. https://orcid.org/0000-0001-8019-9272
,
Agostini, H.
Aires, I. D.
Altay, L.
Atia, R.
Bandello, F.
Basile, P. G.
Batuca, J.
Behning, C.
Belmouhand, M.
Berger, M.
Binns, A.
Boon, C. J. F.
Böttger, M.
Brazier, J. E.
Carapezzi, C.
Carlton, J.
Carneiro, A.
Charil, A.
Coimbra, R.
Cosette, D.
Cozzi, M.
Crabb, D. P.
Cunha-Vaz, J.
Dahlke, C.
Dunbar, H.
Finger, R. P.
Fletcher, E.
Gutfleisch, M.
Hartgers, F.
Higgins, B.
Hildebrandt, J.
Höck, E.
Hogg, R.
Holz, F. G.
Hoyng, C. B.
Kilani, A.
Krätzschmar, J.
Kühlewein, L.
Larsen, M.
Leal, S.
Lechanteur, Y. T. E.
Lu, D.
Luhmann, U. F. O.
Lüning, A.
Manivannan, N.
Marques, I.
Martinho, C.
Miliu, A.
Moll, K. P.
Mulyukov, Z.
Paques, M.
Parodi, B.
Parravano, M.
Penas, S.
Peters, T.
Peto, T.
Priglinger, S.
Ramamirtham, R.
Ribeiro, R.
Rowen, D.
Rubin, G. S.
Sahel, J.
Sánchez, C.
Sander, O.
Saßmannshausen, M.
Schmid, M.
Schmitz-Valckenberg, S.
Siedlecki, J.
Silva, R.
Souied, E.
Staurenghi, G.
Tavares, J.
Taylor, D. J.
Terheyden, J. H.
Tufail, A.
Valmaggia, P.
Varano, M.
Wolf, A.
Zakaria, N.
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (116076, 116076, 116076, 116076, 116076, 116076, 116076, 116076, 116076, 116076)
- License Information
-
More Information
Article History
Received: 13 June 2024
Revised: 8 December 2024
Accepted: 17 December 2024
First Online: 5 February 2025
Competing interests
: Jan Henrik Terheyden: Heidelberg Engineering, Optos, Zeiss, CenterVue (now iCare), Novartis, Okko. Hannah M. P. Dunbar: Boehringer Ingelheim. Steffen Schmitz-Valckenberg: AlphaRET, Apellis, Bayer, Carl Zeiss Meditec, eyeDNA, Formycon, Galimedix, Heidelberg Engineering, Katairo, Kubota Vision, Novartis, Perceivve Therapeutics, Pixium, Roche, Sparing Vision. Charlotte Behning: None. Cecília Martinho: None. Ulrich F.O. Luhmann: Employee of and financial interest in F. Hoffmann-La Roche Ltd. Marlene Saßmannshausen: Heidelberg Engineering, Optos, Zeiss. Anna Lüning: None. Alexandra Miliu: None. Inês Aires: None. Pier Basile: None. Joana Batuca: None. Matthias Schmid: Pixum Vision. Klaus-Peter Moll: Employee of Novartis. Nadia Zakaria: Employee of Novartis. Adnan Tufail: Allergan, Bayer, Kanghong, Heidelberg Engineering, Novartis, Roche/Genentech, Iveric Bio, Apellis, Theá. Alison Binns: Apparatus and method for retinal measurement; Patent number 9492081; Boehringer-Ingelheim. David P. Crabb: Apellis, Santen, Allergan/Abbvie, Janssen; Thea. Sergio Leal: Employee of Bayer Pharma AG. Robert P. Finger: Alimera, Apellis, Bayer, Boehringer-Ingelheim, Novartis, ODOS, Oxford Innovation, ProGenerika, Roche/Genentech, Biogen, Icare, Heidelberg Engineering, Carl Zeiss Meditec. Frank G. Holz: Allergan, Annexon, Alzheon, Apellis, Astellas, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, CenterVue (now iCare), Roche/Genentech, 4D Molecular Therapeuticcs, Geuder, Grayburg, Heidelberg Engineering, IvericBio/Astellas, Janssen, LinBiosciences, NightStarX, Novartis, Optos, Oxurion, Pixium Vision, Stealth BioTherapeutics, Carl Zeiss Meditec, Grade Reading Center.
